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INTRODUCTION
A number of DNA-binding proteins have been separated from the cytoplasm1 ), serum2 - 6 )
and cerebrospinal fluid (7) of a variety of animals. Since some of these DNA-binding proteins
are increased in animals bearing malignant tumors S- S) it has been suggested that determining
their serum levels might aid in the diagnosis of cancer. Recently Kr011 et al. 8) reported that DNA-
binding proteins from Yoshida ascitic fluid can suppress the growth of tumor cells, and other
authors reported that high molecular weight proteins in the serum (nHG-200)9) and cultured
media (160,000)1°) can suppress tumor cell growth in vitro. These observations seem to indicate
that high molecular weight DNA-binding proteins can suppress the growth of tumor cells in
Yoshida ascitic fluid 8). Our present experiments show that high molecular weight DNA-binding
proteins in the ascitic fluid of mice with Meth-A fibrosarcoma can also inhibit tumor growth. The
main protein in this group has a molecular weight of 160,000 daltons.
MATERIALS AND METHODS
Ascites tumor Meth-A ascites fibrosarcoma, serially transplanted in BALB/c mice was kindly
contributed by Dr. K. Kawashima (First Dept. of Internal Medicine, Nagoya University School
of Medicine) and Dr. S. Muramatsu (Faculty of Science, Kyoto University) and transplanted into
syngenic mice in our laboratory.
DNA-affinity chromatography DNA-cellulose was prepared by coupling native calf thymus
DNA (type 1) (Sigma Chemical Co., Mo) to Whatman CF 11 cellulose particles by the method of
Alberts and Herrickll ). DNA-binding proteins were prepared by the method of Parsons et a1. 4 ).
All steps of the procedure were performed at 4°C, and all buffers contained 1 mM EDTA and
1 mM 2-mercaptoethanol. The proteins adsorbed on the DNA-cellulose column were eluted
with 10 mM phosphate buffer (pH 6.8) containing 0.5 M NaCl.
Partial purification of HMDBP The DNA-binding proteins thus obtained were applied to a
DEAE-cellulose (DE 52) column equilibrated with 10 mM phosphate buffer (pH 6.8). The
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column was washed with the same buffer solution until no further protein could be detected in the
eluate. Elution was performed with 10 mM phosphate buffer (pH 6.8) containing 0.12 M KCI,
and the eluates obtained were dialyzed against distilled water and lyophilized. DNA-binding
proteins thus purified were subjected to isoelectric focusing chromatography carried out under pH
gradients between 5.0 and 8.0. A subfraction fractionated at pH 4.8 was collected and developed
on Sephadex G-25 column chromatography. The protein thus obtained was rechromatographed
on a Sephadex G-200 column (3 X 90 cm) equilibrated with 20 mM phosphate buffer (pH 7.2)
containing 0.14 M KCl. The first peak was pooled as HMDBP.
Calculation of molecular weight of HMDBP Sodium dodecyl-sulfate polyacrylamide gel
electrophoresis was employed for calculating the molecular weights of proteins by the method of
Weber and Osborn12). Heat resistant RNA polymerase B proteins (Seikagaku Kogyo Co., Ltd.,
Tokyo) were used as markers.
Immunoelectrophoresis and Ouchterlony test Immunoelectrophoresis was performed on 1.0°1<>
agarose with 0.1 1\1 veronal buffer (pH 6.8) containing 2 mM calcium lactate. The Ouchterlony
test was performed in 1.0% agarose with PBS (pH 7.2). Rabbit antisera against mouse immuno-
globulins, IgA, IgM and IgG, and against whole mouse serum were purchased from MBL, Ltd.,
Nagoya. Antiserum against 160,000 dalton protein was produced in rabbits in our laboratory,
and the antigen used for immunization was separated from sodium dodecylsulfate polyacrylamide
gel electrophoresis by the method of Weintraub et al. 13).
A mount ofprotein The amount of protein was determined by the method of Lowry et al. 14).
Inhibition assay of tumor cell growth in vitro Assays were carried out in a low concentration of
fetal calf serum (FCS) by the method of Holly et al. 15). These conditions are very useful in assay-
ing cell growth inhibition, because small quantites of samples can be tested. The conditions
employed were different from their FCS concentrations. Meth-A fibrosarcoma cells were
suitable to grow in 0.3°1<> rather than 0.1% FCS. Meth-A fibrosarcoma (3 X 105 cells) was cultur-
ed in Dulbecco's modified Eagle medium (DEM) containing 50/0 FCS in a 60 mm Petri dish. A
xenogeneic cell line, HeLa S3, was cultured in DEM containing 100/0 FCS. Twenty four hours
after the initiation of these cultures, the medium was replaced by DEM containing 0.3% FCS
and cultured for 48 hrs. Highly purified HMDBP diluted with DEM to a final concentration of
10 JLg/ml was added to the culture at the time of the medium change. For examining 3H-
thymidine incorporation, 1 JLCi of 3H-thymidine (New England Nuclear, Boston, Mass.) dissolved
in PBS (pH 7.2) to a final concentration of 10 fLCi/ml was added to each dish when the medium
was changed. The cultured cells were w~shedwith cold PBS (pH 7.2) three times at the termina-
tion of culture in order to remove free 3H-thymidine. The cellular material was dissolved in
N aOH at 56°C, and DNA fractions were precipitated by 10% trichloroacetic acid. The precipi-
tates were dissolved in 28% ammonium hydroxide, mixed with 10 ml of Univer-gel (Nakarai
Chemicals, Ltd., Kyoto), kept overnight, and the radioactivity was counted in a Packard Tri-Carb
liquid scintillation counter. In addition to the radioactivity measurement, the number of cultured
cells at the initiation and the termination of culture was calculated with a Coulter counter. These
experiments were carried out in duplicate.
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Partialpurijicatiotl and characteristics of HMDBP The DN A-binding proteins obtained from
mouse ascites tumor fluid were separated on disc-gel electrophoresis in 5% polyacrylamide gel.
Fig. 1 shows the patterns obtained when the blocks were stained with Coomassie brilliant blue.
Fifteen or more protein fraction were demonstrated in the first disc in which the D N A- binding
protein fraction was separated. The major high molecular weight proteins were calculated to be
160,000 and 200,000 or more daltons in molecular weight (Fig. I-a). All DNA-binding proteins






Fig. 1. Steps in purification of HMDBP from DNA-binding proteins on 5% sodium dodecylsulfate
polyacrylamide gel electrophoresis. Each sample was dissolved in 50 mM phosphate lmffer
(pH 7.2) containing 5% SDS and 2% 2-mercaptoethanol and boiled in a water bath at
900 e for 90 seconds. (a): DNA-binding proteins in ascitic fluid, (b): 0.12 M KCI eluates
from DNA-lJinding proteins on DEAE-cellulose, (c): pH 4.8 fraction in isoelectric focusing,
(d): partially purified HMDBP from Sephadex G-200 gel chromatography.
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Fig. 2-(a). Immunoelectrophoretic pattern of HMDBP. (a): 200 p,g of normal mouse serum,
(b): rabbit anti-mouse serum anti-serum, (c): 10 p,g of partially purified HMDBP.
Fig. 2-(b). Ouchterlony test of HMDBP. (A): Anti-mouse IgG antiserum, (B): anti-mouse IgA
antiserum, (C): anti-mouse IgM antiserum, (D): anti-mouse serum antibody, (E):
anti-mouse HMDBP (160,000) antiserum, (F): 10 p,g of HMDBP.
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DNA-binding proteins were chromatographed on DEAE-cellulose, and high molecular weight
glycoproteins were eluted with 10 mM phosphate buffer (pH 6.8) containing 0.12 M KCl (Fig.
I-b). In the DEAE-cellulose column eluted with 0.12 M KCI about 20 mg of protein was
recovered from the 130 mg in the starting fraction. The 0.12 M KCI fraction was found to be
contaminated with immunoglobulins. To separate HMDBP from the immunoglobulins, iso-
electric focusing column chromatography was performed (Fig. I-c), because the isoelectric point
of HMDBP is at pH 4.8, while that of the immunoglobulins is at pH 6.0 or more. A pH 5.0 to
8.0 gradient was chosen because HMDBP becomes insoluble when the electric focusing voltage is
raised from 400 to 1,000. This means that HMDBP is an acidic protein. The precipitates at
pH 4.8 were purified on Sephadex G-200 gel chromatography to isolate HMDBP (Fig. I-d).
Recovery was about 3 mg of protein from 100 ml of ascites tumor fluid.
.Immunochemical analysis Fig. 2-a shows the immunoelectrophoresis patterns of mouse serum
and HMDBP on agarose gel. The precipitation line between HMDBP and anti-mouse serum
antibodies is visualized as a line at the ,B-region of mouse serum. Fig. 2-b shows precipitation
lines in agarose by the double diffusion test. Distinct precipitation lines are visible between
HMDBP and its antibodies and between HMDBP and anti-mouse serum antibodies, the pre-





















Fig. 3. Tumor cell growth in culture media with and
without HMDBP. Meth-A fibrosarcoma (0--0)
and (e--e) were assayed in DEM containing
0.3% FCS. (a): incorporation of 3H-thymidine,
and (b): number of tumor cells.
Concentration of HMDBP
(~g/dishJ
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HMDBP and antibodies against mouse immunoglobulin subclasses.
Suppression by HMDBP of tumor cell growth in vitro Fig. 3 shows the results of in vitro
experiments. Meth-A fibrosarcoma cells in control dishes increased to about 1.7 times the origi-
nal number during the period from the medium change to the end of culture when DEM was
supplemented with 0.3% FC8. The proliferation of tumor cells was suppressed by 700/0' when
8.0 fLg of HMDBP was adeed (Fig. 3-a and -b). The HMDBP obtained from Meth-A ascitic
fluid of BALB/c mice suppressed the isogeneic tumor as described above, but this protein also
suppressed the growth of xenogeneic tumor cells from BeLa 83. These tumor cells increased to
1.6 times the number at the start of culture in DEM containing 0.3% FCS. Incorporation of
3H-thymidine into HeLa 83 cells was suppressed to neally the same degree as incorporation of
3H-thymidine into Meth-A fibrosarcoma cultivated in culture media supplemented with 0.3% FCS
containing HMDBP (Fig. 3-a).
DISCUSSION
A number of studies on DNA-binding proteins have been reported. These were found in
the serum and body fluids of several animal species2), in human cerebrospinal fluid 7), in rat
Yoshida ascitic fluidS) and recently in the serum of patients with malignant diseases 3 - S). These
DNA-binding proteins were reported to migrated from a- to f3-regions on immunoelectrophoresis.
Degradation products of C3 4 ) and of fibronectin S ) are examples of f3-region components. In
contrast, a-component involves several immunosuppressive factors such as a-fetoprotein16 ) and
immunoregulatory a2-g10bulin17).
In the present experiments, DNA-binding proteins were obtained from the ascitic fluid of
Meth-A fibrosarcoma-bearing mice, and the main fraction had a molecular weight of 160,000
daltons. The fraction was separated and purified on DEAE-cellulose column and by isoelectric
focusing. Purified HMDBP is an acidic glycoprotein migrating on immunoelectrophoresis to the
,8-globulin region. The main protein (160,000) in HMDBP has not more than two subunits
covalently bound by disulfide bonds, so it is different from the nine coplement components and
immunoglobulin subclasses. Interestingly enough, it can suppress the growth of syngeneic
Meth-A fibrosarcoma and of xenogeneic HeLa 83 in vitro. Three DNA-binding proteins have
been obtained from rat Yoshida sarcoma ascitic fluid which also appear to be able to suppress
tumor cell growth; their molecular weights are 200,000 or more, 150,000 (IgG), and 100,000 or
less daltonsS). From the serum of patients with malignant disease, two DNA-binding proteins
with molecular weights of 170,000 and 140,000 daltons have also been isolated6 ). Therefore,
HMDBP is unique among the DNA-binding proteins.
Recently attention has been focused on the control of cell growth by proteins in serum or
exudates. First, Kr011 et al. S) described some of the proteins which can suppress tumor cell
growth in vitro. N ext, a-globulin from normal human serum was shown to inhibit the growth of
mitogen-stimul~tedlymphoid cells18) and tumor cells9 ). A soluble factor from tumor cells, the
molecular weight of which was 140,000 daltons, inhibited the multiplication of various cells in
vitro19). The contact-inhibitory culture medium in which melanoma cells had grown inhibited
the growth of various tumor cells, and the active principle was found to have a molecular weight of
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160,000 daltons 10). The HMDBP obtained from Meth-A fibrosarcoma ascitic fluid is a partially
purified fraction of DNA-binding proteins, and the active principle may be 160,000 daltons. This
suppressed the growth of mouse Meth-A fibrosarcoma cells and of human HeLa 83 cells in vitro.
The tumor suppressing activity of HMDBP has been shown in the present experiments. It
seemes to inhibited the growth of various types of tumor cells. The active principle in HMDBP
needs to be purified further. Although the mode of action is not yet known, HMDBP, as found
in serum and/or exudates but not in subcutaneous solid tumors (data not shown), appear to be able
to counteract certain tumor growth-stimulating factors.
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SUMMARY
A high molecular weight DNA-binding protein (HMDBP), from the ascitic fluid of mice
with Meth-A ascites, was partially purified with isoelectric focusing column chromatography.
The HMDBP was shown to be acidic in isoelectrophoresis. It did not cross-react with IgA,
IgM and IgG. The major HMDBP was determined, by sodium dodecylsulfate gel electro-
phoresis, to be about 160,000 daltons. In tumor cell cultures, HMDBP suppressed the growth
of tumor cells. Therefore, this high molecular weight DNA-binding ,B-globulin may playa role
in controlling tumor growth.
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